10
Jul, 2026
Business Exhibition
Ta Fong Pharmaceutical Participates in CPHI South East Asia 2026 to Strengthen Global Partnerships
Ta Fong Pharmaceutical participated in CPHI South East Asia 2026, one of the most influential pharmaceutical exhibitions in the region, where we engaged with pharmaceutical companies, distributors, and industry partners from Southeast Asia and around the world. Through this event, Ta Fong Pharmaceutical actively explored new business opportunities and strengthened connections with potential partners in international markets.
CPHI South East Asia serves as a key platform for pharmaceutical professionals to exchange insights on market trends, regulatory developments, and business opportunities across the ASEAN region and beyond. During the exhibition, Ta Fong Pharmaceutical showcased our comprehensive manufacturing capabilities and introduced a range of pharmaceutical products with potential for international market expansion.
-
At the exhibition, Ta Fong Pharmaceutical presented our expertise in various dosage forms, including injectable preparations, oral solid dosage forms, and topical products. With extensive manufacturing experience, a robust quality management system, PIC/S GMP-certified facilities, and flexible cooperation models, we received valuable interest from potential partners seeking reliable pharmaceutical manufacturing and collaboration opportunities. -
The exhibition provided an excellent opportunity for Ta Fong Pharmaceutical to connect with new customers from ASEAN member countries and gain deeper insights into regional market demands, product development trends, and regulatory requirements. Through face-to-face discussions with industry professionals, we established initial connections with potential partners and explored future opportunities in areas such as product registration, distribution partnerships, and international market expansion. -
We sincerely appreciate all partners and industry professionals who visited our booth and shared valuable insights during the exhibition. Your support and recognition continue to motivate us in pursuing global collaboration.Moving forward, Ta Fong Pharmaceutical will continue to uphold our commitment to “Quality, Integrity, and Healthcare Excellence”, leveraging our manufacturing expertise and professional services to build long-term partnerships worldwide and contribute to improving global healthcare.
-
-
